ACM
TNGX icon

ADAR1 Capital Management’s Tango Therapeutics TNGX Stock Holding History

ADAR1 Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
76,761
+26,761
+54% +$662K 0.11% 135
2026
Q1 		$1.05M Sell
50,000
-90,021
-64% -$1.25M 0.06% 154
2025
Q4 		$1.24M Buy
+140,021
New +$1.21M 0.09% 122
2025
Q2 		– Sell
-41,346
Closed -$56.6K – 237
2025
Q1 		$56.6K Buy
+41,346
New +$102K 0.01% 178

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

ADAR1 Capital Management's TNGX Position: Q2 2026 in Review

ADAR1 Capital Management increased its Tango Therapeutics (TNGX) stake by 54% in Q2 2026, buying an estimated $662K and bringing the position to 76,761 shares worth $2.4M. The position accounts for 0.11% of the portfolio, ranked #135.

ADAR1 Capital Management first reported a position in TNGX in Q1 2025 and has held it in 4 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • ADAR1 Capital Management held 76,761 shares of Tango Therapeutics worth $2.4M as of Q2 2026.
  • ADAR1 Capital Management bought 26,761 Tango Therapeutics shares in Q2 2026, an estimated $662K.
  • Tango Therapeutics made up 0.11% of ADAR1 Capital Management's portfolio in Q2 2026, its #135 holding.
  • ADAR1 Capital Management first reported a position in Tango Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.